Financial statements Mezoderm
Balance sheet data of MEZODERM
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|---|---|---|---|---|
Total assets | 481 574,46 | 633 894,14 | 724 666,05 | 737 827,25 | 500 166,17 |
A. Fixed assets | 18 535,08 | 22 873,60 | 4 583,28 | 0,00 | 15 444,49 |
B. Current assets | 463 039,38 | 611 020,54 | 720 082,77 | 737 827,25 | 484 721,68 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 481 574,46 | 633 894,14 | 724 666,05 | 737 827,25 | 500 166,17 |
A. Equity | 365 142,71 | 492 040,66 | 566 821,76 | 574 640,63 | 481 578,98 |
B. Liabilities and provisions for liabilities | 116 431,75 | 141 853,48 | 157 844,29 | 163 186,62 | 18 587,19 |
I. Long-term liabilities | 0,00 | 0,00 | 108 000,00 | 72 000,00 | 0,00 |
II. Short-term liabilities | 116 431,75 | 136 178,03 | 49 844,29 | 88 153,29 | 18 587,19 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.